China Health Group Inc.
8225.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$78.63M
Close$
$0.01
85.9% downside
Current Fair Value
85.9% downsideOvervalued by 85.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $78.63 Million |
|---|---|
| Enterprise Value | $45.87 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.01 |
| Beta | -0.42 |
| Outstanding Shares | 995,351,660 |
Return
| Return on Equity | -14.73% |
|---|---|
| Return on Assets | -9.65% |
| Return on Invested Capital | 3.43% |
Valuation & Multiples
| P/E Ratio | -3.13 |
|---|---|
| PEG | -2.71 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.05 |
| Enterprise Value to EBIT | 20.83 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About China Health Group Inc.
33 employees
CEO: Zhuang Xiangsong China Health Group Inc., an investment holding company, researches and develops drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China. The company offers contracted pharmaceutical development and clinical...